Lot Release Certificate View

Lot Release Number 2020-10-21-0269
FDA Registered Product/Generic Name Diphtheria, Tetanus, Pertussis (Acellular Component), Hepatitis B, Poliomyelitis (Inactivated) and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) [DTap-IPV-HepB-Hib]
Brand Name Hexaxim
Dosage Strength -
Dosage Form Suspension for Injection
Registration Number BR-919
Batch/Lot Number R3M01
Packaging Lot Packaging lot: BOX: R3M014V, PFS: R3M01 Needle 25Gx5/8": 2001002, ED: 2024-12-31; Needle 23Gx1": 1909035, ED: 2024-08-31
Product Expiration Date 31 August 2021
Issuance Date 26 October 2020